Chief Executive Officer
Jesse Shefferman, Chief Executive Officer (CEO), ArTara Therapeutics, has spent over a decade in the biopharmaceutical industry in strategy and financial roles, most of that time focused on rare and orphan diseases. Prior to co-founding ArTara, Mr. Shefferman was Vice President and Head of Business Development at Retrophin Inc., a rare diseases company where he was a member of the executive leadership team and led the team that identified and executed a number of company-defining transactions.
Prior to Retrophin, Mr. Shefferman was with Vertex Pharmaceuticals in business development and corporate strategy where he focused on the hepatology and rare diseases sectors. Mr. Shefferman was previously an investment banker with Barclays Capital and Lehman Brothers, where he focused on providing strategic and financial advice to management teams and boards of directors of biopharmaceutical companies.
Mr. Shefferman holds an MBA and certificate in health sector management from Duke University and a BA in Accounting from Gordon College.